We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
I Agree
Email registered. Please sign in.×
Enter your contact to build trust with supplier(s)×
One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email :PharmaSources@imsinoexpo.com
Whatsapp :+86-13621645194
Brief Introduction
Shandong Shenglu Pharmaceutical Co.,Ltd, established as Shandong Sishui Pharmaceutical Co.Ltd in 1987, was redisignated as Sishui Xierkang Pharmaceutical Co,.Ltd in November, 2001 and then was approved for the current Shandong Shenglu Pharmaceutical Co.,Ltd till now. The company is located in the North Suburb of Sishui County. There is no other large manufacturing site nearby to pollute the environment. In the courtyard, the administrative area, producing area, facility areas and warehouses are designed and located in separated zone to avoid the potential contamination on the production of the finished products.
The company , with RMB 267 million of capital in total , covers the area of 120000m2. More than 180 employees are working in the courtyard of which 130 technicians working in workshops , lab, research and development department as well as equipment department. More than 30 staffs are active as sales representatives . 59 finished products are registered in state FDA including solutions for injections , tablets and capsules. Two workshops of solutions for injection are established in the courtyard enjoying 8 producing lines in total and one workshop of tablets and capsules enjoying one producing line of tablet and one producing line of capsules. The annual output of solutions for injections is 1000 million ampoules, tablets of 1000 million pieces and capsules of 500 million pieces. The promoting network is established to cover 28 provinces throughout China and 14 offshore markets such as Russia, South-eastern countries and African countries .